Piero Fregatti1,2, Marco Gipponi3, Maria Giacchino1, Marco Sparavigna1, Federica Murelli1,2, Maria Luisa Toni4, Maria Teresa Calabrò4, Lina Orsino4, Daniele Friedman1,2. 1. Department Surgical Sciences and Integrated Diagnostic (DISC), School of Medicine, University of Genoa, Genoa, Italy. 2. Breast Surgery Clinic, Ospedale Policlinico San Martino, Genoa, Italy. 3. Breast Surgery Clinic, Ospedale Policlinico San Martino, Genoa, Italy marco.gipponi@hsanmartino.it. 4. Direction Health Professions (DAPS), Ospedale Policlinico San Martino, Genoa, Italy.
Abstract
BACKGROUND: COVID-19 pandemic required a marked re-allocation of healthcare resources, including at Breast Units. A patient-tailored program was developed to assess its efficacy regarding prevention of COVID-19 infection among patients with breast cancer undergoing surgery and healthcare workers (HCWs). PATIENTS AND METHODS: From March 9th to April 9th 2020, 91 patients were selected for elective surgery by means of: i) Pre-hospital screening aimed at avoiding hospitalization of symptomatic or suspicious COVID-19 patients, and ii) prioritisation of surgical procedure according to specific disease features. RESULTS: Eighty-five patients (93.4%) were fit for surgery, while five patients (5.5%) were temporarily excluded through 'telephone triage'; another two patients were excluded at in-hospital triage. A total of 71 out of 85 patients (83.5%) were diagnosed with invasive cancer, most of whom were undergoing breast-conserving surgery (61 out of 85 patients, 71.8%). The mean in-hospital stay was 2.2 days (SD=0.7 days). After hospital discharge, no patient needed re-admission due to post-operative complications; moreover, no COVID-19 infection among patients or HCWs was detected. CONCLUSION: Safe breast cancer surgery was accomplished for both patients and HCWs by means of a careful preoperative selection of patients and in-hospital preventative measures. This screening program can be transferred to high-volume Breast Units and it may be useful in implementing European Community recommendations for prevention of COVID-19 infection. Copyright
BACKGROUND:COVID-19 pandemic required a marked re-allocation of healthcare resources, including at Breast Units. A patient-tailored program was developed to assess its efficacy regarding prevention of COVID-19infection among patients with breast cancer undergoing surgery and healthcare workers (HCWs). PATIENTS AND METHODS: From March 9th to April 9th 2020, 91 patients were selected for elective surgery by means of: i) Pre-hospital screening aimed at avoiding hospitalization of symptomatic or suspicious COVID-19patients, and ii) prioritisation of surgical procedure according to specific disease features. RESULTS: Eighty-five patients (93.4%) were fit for surgery, while five patients (5.5%) were temporarily excluded through 'telephone triage'; another two patients were excluded at in-hospital triage. A total of 71 out of 85 patients (83.5%) were diagnosed with invasive cancer, most of whom were undergoing breast-conserving surgery (61 out of 85 patients, 71.8%). The mean in-hospital stay was 2.2 days (SD=0.7 days). After hospital discharge, no patient needed re-admission due to post-operative complications; moreover, no COVID-19infection among patients or HCWs was detected. CONCLUSION: Safe breast cancer surgery was accomplished for both patients and HCWs by means of a careful preoperative selection of patients and in-hospital preventative measures. This screening program can be transferred to high-volume Breast Units and it may be useful in implementing European Community recommendations for prevention of COVID-19infection. Copyright
Authors: Amjad Soltany; Mohammed Hamouda; Ansam Ghzawi; Ahmed Sharaqi; Ahmed Negida; Shaimaa Soliman; Amira Yasmine Benmelouka Journal: Ann Med Surg (Lond) Date: 2020-07-09
Authors: Davide Pertile; Marco Gipponi; Alessandra Aprile; Paola Batistotti; Carol Marzia Ferrari; Andrea Massobrio; Domenico Soriero; Lorenzo Epis; Stefano Scabini Journal: In Vivo Date: 2021 Mar-Apr Impact factor: 2.155
Authors: Fabio Pelle; Sonia Cappelli; Franco Graziano; Loredana Piarulli; Flavia Cavicchi; Domenico Magagnano; Assunta De Luca; Roy De Vita; Marcello Pozzi; Maurizio Costantini; Antonio Varanese; Massimo Panimolle; Pietro Paolo Gullo; Maddalena Barba; Patrizia Vici; Enrico Vizza; Francesco Cognetti; Giuseppe Sanguineti; Elena Saracca; Gennaro Ciliberto; Claudio Botti Journal: J Exp Clin Cancer Res Date: 2020-08-27
Authors: Yung Lee; Abirami Kirubarajan; Nivedh Patro; Melissa Sam Soon; Aristithes G Doumouras; Dennis Hong Journal: Am J Surg Date: 2020-11-12 Impact factor: 2.565